Anavex Life Sciences Corp (AVXL)
9.11
+0.09
(+1.00%)
USD |
NASDAQ |
Nov 22, 16:00
9.075
-0.04
(-0.38%)
After-Hours: 20:00
Anavex Life Sciences Free Cash Flow: -30.00M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -30.00M |
| March 31, 2024 | -32.48M |
| December 31, 2023 | -29.31M |
| September 30, 2023 | -27.78M |
| June 30, 2023 | -25.98M |
| March 31, 2023 | -25.38M |
| December 31, 2022 | -26.53M |
| September 30, 2022 | -24.24M |
| June 30, 2022 | -27.87M |
| March 31, 2022 | -28.34M |
| December 31, 2021 | -26.01M |
| September 30, 2021 | -30.38M |
| June 30, 2021 | -28.96M |
| March 31, 2021 | -25.49M |
| December 31, 2020 | -23.43M |
| September 30, 2020 | -21.29M |
| June 30, 2020 | -17.57M |
| March 31, 2020 | -21.02M |
| December 31, 2019 | -20.09M |
| September 30, 2019 | -18.53M |
| June 30, 2019 | -20.05M |
| March 31, 2019 | -14.63M |
| December 31, 2018 | -13.12M |
| September 30, 2018 | -12.58M |
| June 30, 2018 | -10.72M |
| Date | Value |
|---|---|
| March 31, 2018 | -11.61M |
| December 31, 2017 | -9.484M |
| September 30, 2017 | -9.017M |
| June 30, 2017 | -8.689M |
| March 31, 2017 | -7.938M |
| December 31, 2016 | -9.143M |
| September 30, 2016 | -9.237M |
| June 30, 2016 | -8.807M |
| March 31, 2016 | -8.013M |
| December 31, 2015 | -6.781M |
| September 30, 2015 | -4.227M |
| June 30, 2015 | -3.710M |
| March 31, 2015 | -3.240M |
| December 31, 2014 | -2.918M |
| September 30, 2014 | -2.662M |
| June 30, 2014 | -2.229M |
| March 31, 2014 | -1.302M |
| December 31, 2013 | -1.083M |
| September 30, 2013 | -0.7776M |
| June 30, 2013 | -0.545M |
| March 31, 2013 | -0.7515M |
| December 31, 2012 | -0.7364M |
| September 30, 2012 | -1.693M |
| June 30, 2012 | -2.364M |
| March 31, 2012 | -3.331M |
Free Cash Flow Range, Past 5 Years
-32.48M
Minimum
Mar 2024
-17.57M
Maximum
Jun 2020
-25.90M
Average
-26.01M
Median
Dec 2021
Free Cash Flow Benchmarks
| Microbot Medical Inc | -8.97M |
| Alaunos Therapeutics Inc | -11.76M |
| SELLAS Life Sciences Group Inc | -33.07M |
| Galectin Therapeutics Inc | -33.68M |
| Oragenics Inc | -7.682M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.18M |
| Cash from Financing (Quarterly) | 4.55M |
| Free Cash Flow Per Share (Quarterly) | -0.0613 |
| Free Cash Flow Yield | -3.98% |